It has been demonstrated that diabetes promotes aberrant tau modifications through insulin signaling in humans and animal models, and the prevalent hypothesis is that hyperphosphorylation, and misfolding and fibrillization of tau impair synaptic plasticity (Qu et al., 2011; Wang & Mandelkow, 2015). Here, MAPT is linked to diabetes mellitus.